Cargando…

Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial

BACKGROUND: Over a third of multiple myeloma (MM) patients report clinical levels of depression during autologous stem cell transplant (ASCT) hospitalization. We report preliminary results from a randomized clinical trial investigating the effect of Programmed Environmental Illumination (PEI) of hos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdimarsdottir, Heiðdís B., Figueiro, Mariana G., Holden, William, Lutgendorf, Susan, Wu, Lisa M., Ancoli‐Israel, Sonia, Chen, Jason, Hoffman‐Peterson, Ariella, Granski, Julia, Prescott, Nina, Vega, Alejandro, Stern, Natalie, Winkel, Gary, Redd, William H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144249/ https://www.ncbi.nlm.nih.gov/pubmed/30099857 http://dx.doi.org/10.1002/cam4.1690

Ejemplares similares

Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2018)

Complete response after autologous stem cell transplant in multiple myeloma
por: Kumar, Lalit, et al.
Publicado: (2014)

Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
por: Andronesi, Andreea G., et al.
Publicado: (2019)

Stress-related disorders and subsequent cancer risk and mortality: a population-based and sibling-controlled cohort study in Sweden
por: Tian, Fan, et al.
Publicado: (2022)

Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
por: Gu, Jingli, et al.
Publicado: (2021)

Portrait of an autologous cancer vaccine: Then and now
por: Berd, David
Publicado: (2023)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response
por: Lehners, Nicola, et al.
Publicado: (2017)

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
por: Gao, Wen, et al.
Publicado: (2020)

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
por: Dillman, Robert O., et al.
Publicado: (2023)

How Much Information Do Icelandic Men Receive on Pros and Cons of Prostate-Specific Antigen Testing Prior to Undergoing Testing?
por: Eiriksdottir, Valgerdur Kristin, et al.
Publicado: (2022)

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo
por: Tandon, Vasudha, et al.
Publicado: (2022)

Non-invasive detection of corneal sub-basal nerve plexus changes in multiple myeloma patients by confocal laser scanning microscopy
por: Koschmieder, Anita, et al.
Publicado: (2020)

Inhibitory feedback control of NF-κB signalling in health and disease
por: Prescott, Jack A., et al.
Publicado: (2021)

Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
por: Vaughn, John L., et al.
Publicado: (2021)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003‐2016
por: Ellington, Taylor D., et al.
Publicado: (2020)

Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery
por: Thorsteinsdottir, Thordis, et al.
Publicado: (2013)

IKKα plays a major role in canonical NF-κB signalling in colorectal cells
por: Prescott, Jack A., et al.
Publicado: (2022)

Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2021)

Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation
por: Suzuki, Koji, et al.
Publicado: (2013)

Epidemiology of multiple myeloma in 17 Latin American countries: an update
por: Curado, Maria Paula, et al.
Publicado: (2018)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2016)

Differential roles and regulation of the protein kinases PAK4, PAK5 and PAK6 in melanoma cells
por: Murugesan, Gavuthami, et al.
Publicado: (2022)

S-nitrosothiols and H(2)S donors: Potential chemo-therapeutic agents in cancer
por: Reis, Adriana Karla Cardoso Amorim, et al.
Publicado: (2019)

The mechanism study of miR‐125b in occurrence and progression of multiple myeloma
por: Gao, Da, et al.
Publicado: (2017)

Effects of RhoC downregulation on the angiogenesis characteristics of myeloma vascular endothelial cells
por: Zhao, Zhihua, et al.
Publicado: (2019)

Predictive role of diffusion‐weighted whole‐body MRI (DW‐MRI) imaging response according to MY‐RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry
por: Belotti, Angelo, et al.
Publicado: (2021)

Response to pneumococcal vaccination in multiple myeloma
por: Renaud, Loïc, et al.
Publicado: (2019)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
por: Gregersen, Henrik, et al.
Publicado: (2017)

Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
por: Stefka, Andrew T., et al.
Publicado: (2019)

The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without a t(11;14) translocation
por: Sundaramoorthy, Pasupathi, et al.
Publicado: (2018)

Illuminating Targets of Bacterial Secretion
por: Pechous, Roger D., et al.
Publicado: (2015)

Mortality of lung cancer as a second primary malignancy: A population‐based cohort study
por: Deng, Lei, et al.
Publicado: (2019)

Autologous transplant for myeloma: when the old meets the new
por: Gay, Francesca, et al.
Publicado: (2017)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
por: Minnie, Simone A., et al.
Publicado: (2021)

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
por: Farrell, Mariah, et al.
Publicado: (2023)

Illuminating a new path to multicellularity
por: Datta, Sayantan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7h1e3aloufeargn3m446ldthjb